FITC標記的Allgrove綜合征相關(guān)蛋白抗體

FITC標記的Allgrove綜合征相關(guān)蛋白抗體
英文名稱：Anti-Adracalin/FITC
中文名稱別名：AAA; AAAS; AAASb; Achalasia adrenocortical insufficiency alacrimia (Allgrove triple A); Achalasia adrenocortical insufficiency alacrimia; ADRACALA; Aladin; Allgrove triple A; DKFZp586G1624; GL003; AAAS_HUMAN.
規(guī)格：100ul
研究領(lǐng)域：細胞生物   免疫學(xué)   發(fā)育生物學(xué)   神經(jīng)生物學(xué)    細胞類型標志物
抗體來源  ：兔
克隆類型：多克隆
標記一抗訂購
交叉反應(yīng)：Human, Mouse, Rat, Cow,
產(chǎn)品應(yīng)用：ICC = 1：50-200 IF = 1：50-200
在其他應(yīng)用程序尚未進行測試。
最佳稀釋/濃度：應(yīng)該由最終用戶來確定。
分子量:約為60kDa
性狀：凍干或液體
濃度：為1mg / ml
亞型IgG抗體
純化方法：affinity purified by Protein A
儲存液防腐劑：15毫米的疊氮化鈉，成分：1％BSA，0.01M的PBS，pH 7.4中
保存條件：儲存在-20℃一年。避免反復(fù)冷凍/解凍循環(huán)。當(dāng)保持在-20℃下凍干抗體是在室溫下穩(wěn)定至少一個月，對于大于一年。當(dāng)在無菌的pH 7.4的0.01M PBS或抗體的稀釋液重構(gòu)的抗體可穩(wěn)定至少兩周，在2-4℃。
產(chǎn)品圖片：

產(chǎn)品介紹background:
Aladin (Adracalin) belongs to a family of WD repeat-containing proteins. These proteins have a wide variety of functions, including signal transduction regulation, RNA processing and transcription. Aladin plays a role in peripheral and central nervous system development. It is widely expressed, with the highest expression seen in pituitary gland, corpus callosum, cerebellum, adrenal gland and gastrointestinal structures. Defects in Aladin cause the autosomal recessive disorder achalasia-addisonianism-alacrima (triple A) syndrome. Triple A syndrome is characterized by achalasia, alacrima and adrenocortico-tropin-resistant adrenal insufficiency. Robust expression in neural systems associated with cognitive, motor and sensory functions is consistent with the myriad of symptoms experienced by patients with triple A syndrome.

Function:
Adracalin (AAAS) is expressed in both neuroendocrine and cerebral structures and may function in the normal development of the peripheral and central nervous system. It localizes to nuclear pore complexes (NPCs), large multiprotein assemblies that are the sole sites of nucleocytoplasmic transport. Defects in AAAS are the cause of achalasia-addisonianism-alacrima syndrome (AAA syndrome); also known as triple-A syndrome or Allgrove syndrome.

Subcellular Location:
nuclear pore

Tissue Specificity:
Widely expressed. Particularly abundant expression is found in cerebellum, corpus callosum, adrenal gland, pituitary gland, gastrointestinal structures and fetal lung.

DISEASE:
Defects in AAAS are the cause of achalasia-addisonianism-alacrima syndrome (AAAS) [MIM:231550]; also known as triple-A syndrome or Allgrove syndrome. AAAS is an autosomal recessive disorder characterized by adreno-corticotropic hormone (ACTH)-resistant adrenal failure, achalasia of the esophageal cardia and alacrima. The syndrome is associated with variable and progressive neurological impairment involving the central, peripheral, and autonomic nervous system. Other features such as palmoplantar hyperkeratosis, short stature, facial dysmorphy and osteoporosis may also be present.

Similarity:
Contains 4 WD repeats.

Database links:
UniProtKB/Swiss-Prot: Q9NRG9.1

Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

原創(chuàng)作者：青島捷世康生物科技有限公司

標簽：FITC標記的Allgrove綜合征相關(guān)蛋白抗體 Anti-Adracalin/FITC 

您感興趣的產(chǎn)品*
您的單位*
聯(lián)系人*
聯(lián)系電話*
詳細地址*
常用郵箱*
請輸入您對我們的意見或建議*
驗證碼*